$18.74

-1.11%

KVUE

Kenvue Inc.

•Consumer Defensive

Consumer Staples

Dividend Income

Defensive Moat

Corporate Spin-Off

Consumer Staples

Dividend Income

Defensive Moat

Corporate Spin-Off

Loading Chart...

FIT ANALYSIS

Required for personalization

FIT ANALYSIS

Checking Membership...

STOCK DNA

Valuation

7/10

Quality

5/10

Growth

7/10

Strength

4/10

Dividend

7/10

Similar Stocks

HLN Haleon plc

PG Procter & Gamble Company (The)

KMB Kimberly-Clark Corporation

PRGO Perrigo Company plc

CLX Clorox Company (The)

Health Indicators

Price Trend

Upwards

Momentum

Neutral

Balance Sheet

Healthy

Earnings

Growth

Dividend Yield

4.43%

Market Cap

$36.00B

TALK TO YOUR STOCK

EQUITAI ASSISTANT

Kenvue is a pure-play consumer health company that manufactures and markets iconic over-the-counter medications and personal care products. Its portfolio includes globally recognized daily-use brands that generate steady, recession-resistant demand. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.

Talk to Your Stock•open live chat

Pro EquitAI Research

Retrieving premium status...